Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06063317
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2023-09-14
Brief Title:
A Study of OnCARlytics CF33-CD19 in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors OASIS
Sponsor:
Imugene Limited
Organization:
Imugene Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-14
First Submit QC Date:
September 26 2023
Study First Post Date:
2023-10-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL